Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EDIT

Editas Medicine Inc

May 29 • 04:00PM ET

3.46

+0.03 0.87 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NTLA CRSP PRME DTIL RGNX ABEO SLN VYGR MGTX SLDB

| Held by: VTI IWM VXF IWN IBB SCHA VTWO VHT IWC SCHB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.22	Insider Own	0.47%	Shs Outstand	97.87M	Perf Week	29.59%
Market Cap	338.76M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	-2.83%	Shs Float	97.45M	Perf Month	22.70%
Enterprise Value	287.08M	PEG	-	EPS next Q	-0.27	Inst Own	54.10%	Short Float	9.81%	Perf Quarter	57.27%
Income	-108.95M	P/S	8.76	EPS this Y	44.05%	Inst Trans	0.76%	Short Ratio	4.87	Perf Half Y	44.77%
Sales	38.69M	P/B	76.82	EPS next Y	4.03%	ROA	-52.76%	Short Interest	9.56M	Perf YTD	68.78%
Book/sh	0.05	P/C	2.74	EPS next 5Y	16.43%	ROE	-326.07%	52W High	4.54 -23.74%	Perf Year	89.07%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	17.49% 1.84%	ROIC	-175.22%	52W Low	1.66 108.43%	Perf 3Y	-61.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.15% -14.89%	Gross Margin	90.07%	Volatility	16.78% 9.44%	Perf 5Y	-89.81%
Dividend TTM	-	EV/Sales	7.42	EPS Y/Y TTM	59.82%	Oper. Margin	-230.09%	ATR (14)	0.30	Perf 10Y	-90.18%
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	7.97%	Profit Margin	-281.59%	RSI (14)	63.38	Recom	2.08
Dividend Gr. 3/5Y	- -	Current Ratio	3.22	EPS Q/Q	72.14%	SMA20	16.94%	Beta	2.16	Target Price	5.66
Payout	-	Debt/Eq	16.32	Sales Q/Q	-39.22%	SMA50	19.88%	Rel Volume	1.89	Prev Close	3.43
Employees	87	LT Debt/Eq	13.10	Earnings	May 05 BMO	SMA200	29.62%	Avg Volume	1.96M	Price	3.46
IPO	Feb 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.14% -55.58%	Trades		Volume	3,719,097	Change	0.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)